We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

2 Classes Certified In Drug Pricing Suit

Law360 (September 30, 2008, 12:00 AM EDT) -- In a blow to AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co., a federal judge has given the green light to two national classes in the multidistrict litigation over average wholesale drug prices, allowing the plaintiffs to pursue their claims of unfair and deceptive trade practices against the two drug giants.

The two certified classes will include the third-party payor Medigap Supplemental Insurance class and the consumer and third-party payor class for Medicare Part B drugs, Judge Patti Saris said in a ruling Friday in the U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.